共 50 条
Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases
被引:0
|作者:
Kornmann, M
[1
]
Fakler, H
[1
]
Butzer, U
[1
]
Beger, HG
[1
]
Link, KH
[1
]
机构:
[1] Univ Ulm, Dept Gen Surg, D-89075 Ulm, Germany
关键词:
hepatic arterial infusion;
regional chemotherapy;
liver metastases;
colon cancer;
pancreatic cancer;
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background. Oxaliplatin displays potent activity in advanced colorectal cancer. The aim of this study was to estimate the potential efficacy of oxaliplatin for hepatic arterial infusion (HAI) chemotherapy. Materials and Methods. The antiproliferative effects of oxaliplatin in human HT29 and NMG64/84 colon and COLO-357 MIA PaCa-2 and PMH2/89 pancreatic cancel cell lines and in fresh liver metastases from patients with colorectal and pancreatic cancer were investigated using the human tumor colony forming assay. Results. Oxaliplatin significantly inhibited the colony formation in all cell lines in a concentration - and time - dependent manner. All liver armors displayed a significant concentration - dependent inhibition of colony formation after exposure to oxaliplatin for 2 hours. The IC50 of oxaliplatin of 9 of the 10 tumors was < 10 <mu>g/ml. Conclusion: Oxaliplatin is suitable for HAI therapy phase II studies. Due to the low IC50 values of most tumors we suggest that patients with colorectal or pancreatic liver metastases may benefit from HAI with oxaliplatin.
引用
收藏
页码:3259 / 3264
页数:6
相关论文